Not assignedThis week the FDA approved the first new Alzheimer’s drug in nearly two decades.
It’s billed as the first to slow onset of the cognitive disease affecting millions of Americans.
'This is not a cure' -doctor on Alzheimer's drug
Reuters - Politics
Sixty-nine year-old runner and Alzheimer's patient Bill McKay hopes the new Biogen drug will get his life back on track, but his..